Answers are grounded in this paper and cite their sources.
Background Systemic barriers and patient-centered monitoring deficits often undermine tuberculosis (TB) treatment adherence in urban environments, escalating the risk of clinical attrition and multidrug resistance. This study evaluated the association between an integrated Nurse-Led Advocacy Model (NLAM) and therapeutic adherence among patients with pulmonary TB within Zhejiang Province, China.Methods A non-randomized controlled trial was conducted across municipal clinics in Shaoxing, Zhejiang, between August 17, 2023, to August 1, 2025. Following propensity score matching via a 1:1 nearest-neighbor algorithm to eliminate baseline imbalances, 300 patients were evaluated: 152 in the NLAM cohort (received structured, face-to-face advocacy sessions spanning intensive and continuation phases with digital adherence technology (DAT) consisting of an electronic smart pill box and the WeChat-TB mini-program interface and 148 in the routine clinical care (RCC cohort; received standard institutional treatment monitoring).Results Baseline demographic profiles and clinical characteristics were highly balanced between groups (p > 0.05). The NLAM cohort exhibited significantly higher medication adherence across both drug-susceptible (mean ± SD: 94.5% ± 2.6% vs. 82.8% ± 2.9%; p < 0.001) and multidrug-resistant strains (90.9% ± 2.1% vs. 72.3% ± 2.1%; p < 0.001) compared to the RCC group. Longitudinal survival analysis showed a significantly lower rate of cumulative clinical attrition under the advocacy framework (5.3% [8/152] vs. 14.9% [22/148] loss to follow-up events; Relative Risk = 0.35, 95% Confidence Interval: 0.16–0.77; Log-rank p < 0.001). Patient-perceived nursing support based on the Nursing Advocacy Scale was remarkably higher in the NLAM cohort (p < 0.001).Conclusion Structured nurse-led advocacy framework coupled with smart-box digital monitoring is strongly associated with optimized medication adherence, heightened patient-perceived support, and minimized clinical attrition.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: